Secondary Brain Tumours
Main content
Secondary brain tumours, also called brain metastases, are more common than primary brain tumours. Up to 40% of all cancer patients may develop brain metastases, that聽in Europe account for up to 1.5 million people every year. The incidence is increasing, which can partially be explained by improved local control of primary and secondary lesions and/or improved detection methodology.
Brain metastases are most frequently derived from primary cancers localized either in the lung, breast, skin, kidney or colon. Treatment involves聽combinations of surgery, chemotherapy, radiotherapy and radiosurgery. 聽So far there has not been a systematic attempt to develop drugs specifically targeting brain metastases, and often patients with brain metastases聽are聽excluded from new clinical trials involving聽metastatic disease. In the Kristian Gerhard Jebsen Brain Tumour Research Centre, a focus will be聽to acquire more knowledge related to brain metastasis formation and to use such聽knowledge for the development of new effective therapies.
More information related to brain metastasis is provided聽.
